ArticlePLoS neglected tropical diseases2025
Community knowledge and response to Nipah virus infection and its transmission, prevention and control measures: Insights from a cross-sectional survey in Bangladesh.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Nipah virus in the era of global connectivity: molecular evolution, transmission risk, and preparedness strategies.Virus genes · 2026Review
- Assessing Knowledge, Attitudes and Practices Regarding Brucellosis Among High-Risk Occupational Groups.Veterinary medicine and science · 2026Article
- Reframing early warning for Nipah virus in Bangladesh: A shift from detection to anticipation.PLoS neglected tropical diseases · 2026Article
- Review
- Nipah and chandipura viruses: Emerging neurotropic zoonotic viruses in south asia - a comparative review.Molecular biology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNipah virus (NiV) is a zoonotic pathogen with high case-fatality rates, recurring outbreaks, and significant public health implications in Bangladesh, particularly in regions known as the "Nipah belt." This study aimed to assess the knowledge, attitudes, and practices (KAP) of the general population regarding NiV transmission, prevention, and control measures. METHODOLOGY/PRINCIPLE
findingsA cross-sectional survey was conducted from December 2024 to April 2025 among 545 respondents, selected through multi-stage sampling from 48 upazilas across 16 districts. A structured questionnaire, prepared in Bengali and English, covered four domains: sociodemographic characteristics, knowledge, attitude, and practice. Data were collected via face-to-face interviews and reported through KoboToolbox and analyzed using descriptive statistics and logistic regression. Findings revealed that only 29.2% of participants demonstrated good knowledge of NiV infection, while 94.1% showed positive attitudes toward prevention and control. However, correct preventive practices were reported by just 33.0% of respondents. Awareness of bat-to-human transmission was relatively high (66.2%), yet knowledge of the disease's high fatality rate (11.4%) and preventive measures (28.8%) was low. Over half of participants (53.2%) reported consuming raw date palm sap, a key transmission route. Higher education, employment, and proximity to sap collection areas were associated with better knowledge, while younger age, female gender, and higher income were linked to better practices. CONCLUSION/SIGNIFICANCE: This first nationwide community-level KAP survey highlights critical gaps between awareness and behavior, underscoring the need for sustained, culturally tailored interventions, strengthened surveillance, and One Health approaches to reduce NiV spillover and transmission risks in Bangladesh.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.